文献速递区域麻醉与超声疼痛医学

全膝关节置换术后多模式镇痛中关节周围注射的作用:随机盲法安慰剂对照非劣效性试验

What Is the Role of a Periarticular Injection for Knee Arthroplasty Patients Receiving a Multimodal Analgesia Regimen Incorporating Adductor Canal and Infiltration Between the Popliteal Artery and Capsule of the Knee Blocks? A Randomized Blinded Placebo-Controlled Noninferiority Trial.
PubMed 文献 · Anesth Analg · 2024-01-08

主要结局为术后第1天行走时疼痛数字评分(NRS),非劣效界值1.0。

要点

  • 在ACB+IPACK多模式镇痛基础上,生理盐水PAI未证实非劣效于活性PAI。
  • 活性PAI未显示优于生理盐水PAI,两组主要及次要结局均无显著差异。
  • 临床可灵活选择是否在ACB+IPACK基础上加用活性PAI。

核心结论

  • 对于接受综合镇痛方案的全膝关节置换术患者,生理盐水PAI未达到非劣效于活性PAI。
  • 活性PAI在主要和次要结局上均未显示优效性,因此两种技术孰优孰劣无法断言,临床可灵活选用。

研究设计与样本

  • 所有患者采用多模式镇痛方案:脊髓麻醉、ACB和IPACK阻滞、术中氯胺酮和酮咯酸、术后酮咯酸后改用美洛昔康、对乙酰氨基酚、度洛西汀及口服阿片类药物。
  • 患者随机接受活性PAI或对照PAI(生理盐水,相同注射技术和容量)。

主要发现

  • 静息疼痛评分两组无显著差异。
  • 最严重疼痛、严重疼痛时间比例、疼痛干扰、副作用(恶心、嗜睡、瘙痒、头晕)、恢复质量、满意度、住院时间、慢性疼痛及骨科结局均无显著差异。

关键数值与推荐

  • 活性PAI组成分:骨水泥置入前深部注射0.25%布比卡因加肾上腺素30 mL、吗啡、甲泼尼龙、头孢唑林,生理盐水补足至64 mL;缝合前浅层注射0.25%布比卡因20 mL。
  • 对照PAI组:生理盐水,相同注射技术和容量。
  • 主要结局为非劣效性检验,非劣效界值为1.0。

临床怎么用

  • 在ACB+IPACK多模式镇痛方案下,加用活性PAI未显示额外获益,但生理盐水PAI也未证实非劣效。
  • 临床可根据具体情况灵活选择是否加用活性PAI,无需强制统一。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal analgesic protocols for total knee arthroplasty (TKA) patients remain controversial. Multimodal analgesia is advocated, often including peripheral nerve blocks and/or periarticular injections (PAIs). If 2 blocks (adductor canal block [ACB] plus infiltration between the popliteal artery and capsule of the knee [IPACK]) are used, also performing PAI may not be necessary. This noninferiority trial hypothesized that TKA patients with ACB + IPACK + saline PAI (sham infiltration) would have pain scores that were no worse than those of patients with ACB + IPACK + active PAI with local anesthetic. METHODS: A multimodal analgesic protocol of spinal anesthesia, ACB and IPACK blocks, intraoperative ketamine and ketorolac, postoperative ketorolac followed by meloxicam, acetaminophen, duloxetine, and oral opioids was used. Patients undergoing primary unilateral TKA were randomized to receive either active PAI or control PAI. The active PAI included a deep injection, performed before cementation, of bupivacaine 0.25% with epinephrine, 30 mL; morphine; methylprednisolone; cefazolin; with normal saline to bring total volume to 64 mL. A superficial injection of 20 mL bupivacaine, 0.25%, was administered before closure. Control injections were normal saline injected with the same injection technique and volumes. The primary outcome was numeric rating scale pain with ambulation on postoperative day 1. A noninferiority margin of 1.0 was used. RESULTS: Ninety-four patients were randomized. NRS pain with ambulation at POD1 in the ACB + IPACK + saline PAI group was not found to be noninferior to that of the ACB + IPACK + active PAI group (difference = 0.3, 95% confidence interval [CI], [-0.9 to 1.5], P = .120). Pain scores at rest did not differ significantly among groups. No significant difference was observed in opioid consumption between groups. Cumulative oral morphine equivalents through postoperative day 2 were 89 ± 40 mg (mean ± standard deviation), saline PAI, vs 73 ± 52, active PAI, P = .1. No significant differences were observed for worst pain, fraction of time in severe pain, pain interference, side-effects (nausea, drowsiness, itching, dizziness), quality of recovery, satisfaction, length of stay, chronic pain, and orthopedic outcomes. CONCLUSIONS: For TKA patients given a comprehensive analgesic protocol, use of saline PAI did not demonstrate noninferiority compared to active PAI. Neither the primary nor any secondary outcomes demonstrated superiority for active PAI, however. As we cannot claim either technique to be better or worse, there remains flexibility for use of either technique.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. YaDeau JT, Cushner FD, Westrich G, et al. What Is the Role of a Periarticular Injection for Knee Arthroplasty Patients Receiving a Multimodal Analgesia Regimen Incorporating Adductor Canal and Infiltration Between the Popliteal Artery and Capsule of the Knee Blocks? A Randomized Blinded Placebo-Controlled Noninferiority Trial. Anesth Analg. 2024. PMID: 38190339. doi:10.1213/ANE.0000000000006805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。